Atlas FDA

NEOVENTA'S STAN S31 FETAL HEART MONITOR

FDA premarket approval P020001/S006 · decided 2009-11-16

Approval details

PMA number
P020001
Supplement
S006
Supplement type
Real-Time Process
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
NEOVENTA'S STAN S31 FETAL HEART MONITOR
Generic name
Analyzer, data, obstetric
Applicant
Neoventa Medical AB
Date received
2009-09-11
Decision date
2009-11-16
Days to decision
66 days
Decision code
APPR
Product code
HEO
Advisory committee
Obstetrics/Gynecology
Expedited review
No
Location
Molndal
Statement
APPROVAL FOR CHANGES TO THE CLINICAL GUIDELINES. THE DEVICE ASMODIFIED WILL BE MARKETED UNDER THE TRADE NAME STAN S31 FETAL HEART MONITOR AND IS INDICATED FOR USE AS AN ADJUNCT TO FETAL HEART RATE MONITORING TO DETERMINE WHETHER OBSTETRICAL INTERVENTION IS WARRANTED WHEN THERE IS INCREASED RISK OF DEVELOPING METABOLIC ACIDOSIS.THIS DEVICE IS INTENDED FOR USE IN PATIENTS WITH:1) PLANNED VAGINAL DELIVERY;2) >36 COMPLETED WEEKS GESTATION;3) SINGLETON FETUS;4) VERTEX PRESENTATION; AND5) RUPTURED AMN

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Goldtrace Fetal Spiral Electrode (FSE) (CNS000004) (K243291)Neoventa Medical AB2025-01-17